1-6 of 6
Marian Novak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract AP23: EARLY LOSS OF MONOUBIQUITYLATION OF HISTONE H2B ALTERS KEY IMMUNE SIGNALING PATHWAYS PROMOTING THE PROGRESSION OF HIGH-GRADE SEROUS OVARIAN CANCER

Jagmohan Hooda, Marián Novak, Matthew P. Salomon, Emily MacDuffie, Melissa Song, Jenny Lester, Vinita Parkash, Beth Y. Karlan, Moshe Oren, Dave S. Hoon, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): AP23.
DOI: https://doi.org/10.1158/1557-3265.OVCASYMP18-AP23
Published: 15 November 2019
View article
Journal Articles

Abstract B44: Early loss of monoubiquitylation of H2B alters key metabolic and immune signaling pathways promoting the progression of high-grade serous ovarian cancer

Jagmohan Hooda, Marian Novak, Emily MacDuffie, Melissa Song, Jenny Lester, Vinita Parkash, Gordon B. Mills, Beth Y. Karlan, Moshe Oren, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): B44.
DOI: https://doi.org/10.1158/1557-3265.OVCA17-B44
Published: 01 August 2018
View article
Journal Articles

Abstract MIP-060: EPIGENETIC DYSREGULATION OF A HISTONE MARK REVEALS A METABOLIC VULNERABILITY IN OVARIAN CANCER

Jagmohan Hood, Marián Novak, Emily MacDuffie, Jenny Lester, Vinita Parkash, Gordon B. Mills, Beth Y. Karlan, Moshe Oren, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): MIP-060.
DOI: https://doi.org/10.1158/1557-3265.OVCASYMP16-MIP-060
Published: 31 May 2017
View article
Journal Articles

Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics

Joyce F. Liu, Sangeetha Palakurthi, Qing Zeng, Shan Zhou, Elena Ivanova, Wei Huang, Ioannis K. Zervantonakis, Laura M. Selfors, Yiping Shen, Colin C. Pritchard, Mei Zheng, Vilmos Adleff, Eniko Papp, Huiying Piao, Marian Novak, Susan Fotheringham, Gerburg M. Wulf, Jessie English, Paul T. Kirschmeier, Victor E. Velculescu, Cloud Paweletz, Gordon B. Mills, David M. Livingston, Joan S. Brugge, Ursula A. Matulonis, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (5): 1263–1273.
DOI: https://doi.org/10.1158/1078-0432.CCR-16-1237
Published: 28 February 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract PR12: Mutant p53 drives early events in fallopian tube tumorigenesis through mesenchyme-associated autocrine production of matrix that supports survival and mesothelial intercalation.

Marcin P. Iwanicki, Hsing-Yu Chen, Ioannis Zervantonakis, Marian Novak, Taru Muranen, Tan A. Ince, Ronny Drapkin, Joan S. Brugge
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): PR12.
DOI: https://doi.org/10.1158/1557-3265.OVCA15-PR12
Published: 15 January 2016
View article
Journal Articles

Abstract A7: Targeting mutant p53 and cell-cell adhesion in ovarian cancer

Marcin P. Iwanicki, Marian Novak, Ioannis K. Zervantonakis, Tan A. Ince, Ronny Drapkin, Joan S. Brugge
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A7.
DOI: https://doi.org/10.1158/1078-0432.OVCA13-A7
Published: 13 May 2014
View article